Scribe Therapeutics Expands Collaboration With Biogen to Second Target

Go back to Scribe Therapeutics Expands Collaboration With Biogen to Second Target
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 206.45 -2 (0.96%)
Previous Close $208.45    52 Week High $333.65 
Open $210.60    52 Week Low $223.02 
Day High $212.18    P/E 26.43 
Day Low $206.11    EPS $7.81 
Volume 454,085